Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

64
Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
64
Acute Kidney Injury V: Interprofessional Care01:20

Acute Kidney Injury V: Interprofessional Care

51
Acute Kidney Injury (AKI) requires a collaborative healthcare approach to restore renal function and prevent complications. Essential management strategies involve monitoring fluid and electrolyte balance, adjusting medications, initiating dialysis when necessary, and providing nutritional support.Fluid and Electrolyte ManagementFluid Monitoring: Regularly monitoring body weight, central venous pressure, and urine output helps detect fluid imbalances early. Patient intake and output are...
51
Acute Kidney Injury VI: Nursing Management01:22

Acute Kidney Injury VI: Nursing Management

69
Acute Kidney Injury (AKI) results in an inability to maintain fluid, electrolyte, and acid-base balance. Effective nursing management is critical in improving patient outcomes and includes comprehensive patient assessment and targeted interventions.Comprehensive Patient AssessmentA detailed history collection is essential, focusing on any recent infections, nephrotoxic medication use, or chronic conditions such as hypertension and diabetes that may contribute to AKI. During the physical...
69
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

524
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
524
Nephrotic Syndrome III : Nursing Management01:24

Nephrotic Syndrome III : Nursing Management

49
Nursing management for nephrotic syndrome adapts as the disease progresses, with strategies evolving to address advancing symptoms and complications.Early-Stage Management In the early stages, nursing interventions for nephrotic syndrome resemble those used in managing acute glomerulonephritis, focusing on symptom monitoring, fluid balance, and managing mild to moderate edema.Vital Signs: Regularly monitor blood pressure, pulse, respiratory rate, and temperature to promptly identify...
49
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

84
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
84

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Depressive symptoms in chronic kidney disease: the hidden role of uremic toxins.

BMJ mental health·2026
Same author

Anticholinergic Burden and Progression to Kidney Replacement Therapy.

Kidney international reports·2026
Same author

Renal replacement therapy in type 2 severe cardiorenal syndrome: a randomized controlled trial.

ESC heart failure·2026
Same author

Hyperpolypharmacy in patients with chronic kidney disease and its impact on clinical outcomes.

Scientific reports·2026
Same author

ESC/EAS 2025 dyslipidaemia guidelines update: Don't get left behind!

Archives of cardiovascular diseases·2025
Same author

AI-BASED Tool to Estimate Sodium Intake in STAGE 3 to 5 CKD Patients-The UniverSel Study.

Nutrients·2025

相关实验视频

Updated: Sep 18, 2025

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats
05:34

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats

Published on: April 4, 2025

871

[脏保护中的新技术]

Florence Sens1, Maurice Laville1, Laure Groisne2

  • 1Association pour l'utilisation du rein artificiel en région lyonnaise (AURAL), Lyon, France.

La Revue du praticien
|June 23, 2025
PubMed
概括

最近保护方面的进展,包括二型-葡萄糖携运抑制剂 (iSGLT2),为保护成年人功能和减缓慢性病进展提供了新的途径.

科学领域:

  • 腎臟病學 (nephrology) 是一種醫學專業.
  • 心脏病学 心脏病学
  • 内分泌学 在内分泌学.

背景情况:

  • 脏保护策略旨在维护功能并减缓慢性病 (CKD) 的进展.
  • 治疗选择已经显著扩大,可能减少末期功能衰竭的发生率.

研究的目的:

  • 概述CKD成年患者心脏脏保护的最新进展.
  • 强调-葡萄糖携运II型抑制剂 (iSGLT2),也称为gliflozins的作用和应用.

主要方法:

  • 关于脏保护的最新治疗进展的审查.
  • 专注于药理干预措施,包括iSGLT2,类似葡萄糖素的-1类似物和非类固醇矿物质皮质体受体对抗剂.
  • 考虑常规策略,如改变生活方式和氨酸-血管酶-阿尔多斯特系统阻断剂.

主要成果:

  • 慢性病管理的治疗选择显著扩大.
  • iSGLT2抑制剂,GLP-1类似物和非类固醇MRA是新疗法中的关键.
  • 将这些新型药物与已建立的疗法相结合,可以改善心脏脏保护作用.

结论:

  • 最近的进展,特别是iSGLT2抑制剂,代表了在保持功能方面迈出的重要一步.
关键词:
腎不全,慢性腎不全,慢性腎不全.

更多相关视频

Use of a Hanging-weight System for Isolated Renal Artery Occlusion
07:54

Use of a Hanging-weight System for Isolated Renal Artery Occlusion

Published on: July 19, 2011

16.2K
Induction of Nephrotic Syndrome in Mice by Retrobulbar Injection of Doxorubicin and Prevention of Volume Retention by Sustained Release Aprotinin
07:38

Induction of Nephrotic Syndrome in Mice by Retrobulbar Injection of Doxorubicin and Prevention of Volume Retention by Sustained Release Aprotinin

Published on: May 6, 2018

8.5K

相关实验视频

Last Updated: Sep 18, 2025

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats
05:34

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats

Published on: April 4, 2025

871
Use of a Hanging-weight System for Isolated Renal Artery Occlusion
07:54

Use of a Hanging-weight System for Isolated Renal Artery Occlusion

Published on: July 19, 2011

16.2K
Induction of Nephrotic Syndrome in Mice by Retrobulbar Injection of Doxorubicin and Prevention of Volume Retention by Sustained Release Aprotinin
07:38

Induction of Nephrotic Syndrome in Mice by Retrobulbar Injection of Doxorubicin and Prevention of Volume Retention by Sustained Release Aprotinin

Published on: May 6, 2018

8.5K
  • 这些疗法对于减缓CKD进展和改善受影响成人的心血管结果至关重要.
  • 了解使用iSGLT2抑制剂的具体作用和条件对于有效的临床实践至关重要.